Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Common Equity: 2020-2024

Historic Common Equity for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $3.3 million.

  • iSpecimen's Common Equity fell 34.83% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 34.83%. This contributed to the annual value of $3.3 million for FY2024, which is 66.01% down from last year.
  • iSpecimen's Common Equity amounted to $3.3 million in FY2024, which was down 66.01% from $9.7 million recorded in FY2023.
  • In the past 5 years, iSpecimen's Common Equity ranged from a high of $29.8 million in FY2021 and a low of -$27.3 million during FY2020.
  • Over the past 3 years, iSpecimen's median Common Equity value was $9.7 million (recorded in 2023), while the average stood at $11.1 million.
  • As far as peak fluctuations go, iSpecimen's Common Equity spiked by 209.21% in 2021, and later plummeted by 66.01% in 2024.
  • iSpecimen's Common Equity (Yearly) stood at -$27.3 million in 2020, then surged by 209.21% to $29.8 million in 2021, then crashed by 31.83% to $20.3 million in 2022, then plummeted by 52.04% to $9.7 million in 2023, then crashed by 66.01% to $3.3 million in 2024.